We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+7.58%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$2.41B
AUM Growth
-$3.75B
Cap. Flow
-$4.09B
Cap. Flow %
-169.35%
Top 10 Hldgs %
31.78%
Holding
6,989
New
537
Increased
1,703
Reduced
3,620
Closed
686

Sector Composition

Rank Sector Weight
1 Technology 21.71%
2 Healthcare 7.7%
3 Consumer Discretionary 6.83%
4 Financials 6.52%
5 Industrials 4.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FUTU icon
2351
Futu Holdings
FUTU
$14.7B
$50K ﹤0.01%
1,221
+452
+59% +$22.1K
GEL icon
2352
Genesis Energy
GEL
$1.92B
$50K ﹤0.01%
4,946
-59
-1% -$607
INGN icon
2353
Inogen
INGN
$154M
$50K ﹤0.01%
2,562
+75
+3% +$1.61K
NHI icon
2354
National Health Investors
NHI
$3.5B
$50K ﹤0.01%
956
-1,191
-55% -$65.3K
WW
2355
DELISTED
WW International
WW
$50K ﹤0.01%
13,163
+2,379
+22% +$9.53K
SQSP
2356
DELISTED
Squarespace, Inc.
SQSP
$50K ﹤0.01%
2,260
+893
+65% +$18.8K
AAN
2357
DELISTED
The Aaron's Company Inc
AAN
$50K ﹤0.01%
4,196
-2,735
-39% -$29.3K
AMK
2358
DELISTED
AssetMark Financial Holdings, Inc.
AMK
$50K ﹤0.01%
2,136
-2,172
-50% -$47.9K
AVXL icon
2359
Anavex Life Sciences
AVXL
$303M
$49K ﹤0.01%
5,334
-2,598
-33% -$27.8K
BBDC icon
2360
Barings BDC
BBDC
$987M
$49K ﹤0.01%
6,025
+2,968
+97% +$25.7K
BOC icon
2361
Boston Omaha
BOC
$431M
$49K ﹤0.01%
1,836
+295
+19% +$7.74K
CIB icon
2362
Grupo Cibest SA
CIB
$22.7B
$49K ﹤0.01%
1,724
-2,627
-60% -$67.9K
CKPT
2363
DELISTED
Checkpoint Therapeutics
CKPT
$49K ﹤0.01%
9,548
+9,104
+2,050% +$65.6K
COUR icon
2364
Coursera
COUR
$1.53B
$49K ﹤0.01%
4,135
-7,184
-63% -$90.6K
ESLT icon
2365
Elbit Systems
ESLT
$36.5B
$49K ﹤0.01%
296
+36
+14% +$6.75K
HCI icon
2366
HCI Group
HCI
$2.32B
$49K ﹤0.01%
1,236
-376
-23% -$13.8K
IVVD icon
2367
Invivyd
IVVD
$202M
$49K ﹤0.01%
32,628
+30,190
+1,238% +$84K
IYR icon
2368
iShares US Real Estate ETF
IYR
$4.58B
$49K ﹤0.01%
577
-60,237
-99% -$5.06M
MHO icon
2369
M/I Homes
MHO
$3.9B
$49K ﹤0.01%
1,067
-2,768
-72% -$119K
OPEN icon
2370
Opendoor
OPEN
$3.54B
$49K ﹤0.01%
44,480
+34,892
+364% +$66.9K
PCT icon
2371
PureCycle Technologies
PCT
$1.41B
$49K ﹤0.01%
7,126
-2,321
-25% -$16.7K
RKT icon
2372
Rocket Companies
RKT
$42.6B
$49K ﹤0.01%
7,000
-70,995
-91% -$518K
SWIM icon
2373
Latham Group
SWIM
$889M
$49K ﹤0.01%
15,314
+10,349
+208% +$37.3K
CMLS
2374
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$49K ﹤0.01%
7,912
-9,166
-54% -$65.5K
APPN icon
2375
Appian
APPN
$2.65B
$48K ﹤0.01%
1,495
-1,338
-47% -$52.8K

Similar funds

Tower Research Capital (TRC)'s Q4 2022 Portfolio in Review

As of Q4 2022, Tower Research Capital (TRC) held 6,989 positions worth $2.41B, down 61% from $6.16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.09B in Q4 2022, closing 686 positions and reducing 3,620 holdings. Its most notable exit was Vanguard Russell 2000 Value ETF, an estimated $4.46M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Semiconductor ETF worth $9.33M.

  • Tower Research Capital (TRC)'s largest Q4 2022 buy was iShares Semiconductor ETF: 80,454 shares worth $9.33M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2022, an estimated $145M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2022 reduction was Apple, cutting an estimated $322M.
  • Tower Research Capital (TRC) fully exited Vanguard Russell 2000 Value ETF in Q4 2022, selling an estimated $4.46M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $2.41B portfolio in Q4 2022.
  • Tower Research Capital (TRC) opened 537 new positions and closed 686 in Q4 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 61% quarter-over-quarter to $2.41B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.